Bionano Genomics (BNGO) to Release Quarterly Earnings on Tuesday

Bionano Genomics (NASDAQ:BNGO) is anticipated to post its quarterly earnings results before the market opens on Tuesday, March 4th. Analysts expect Bionano Genomics to post earnings of ($8.40) per share and revenue of $6.20 million for the quarter.

Bionano Genomics Stock Performance

BNGO opened at $4.96 on Tuesday. The stock has a market capitalization of $9.69 million, a price-to-earnings ratio of -0.04 and a beta of 2.14. Bionano Genomics has a fifty-two week low of $4.75 and a fifty-two week high of $81.00. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.99 and a current ratio of 1.43. The company has a fifty day moving average of $9.91 and a 200 day moving average of $17.55.

Analyst Ratings Changes

Separately, LADENBURG THALM/SH SH cut Bionano Genomics from a “buy” rating to a “neutral” rating in a report on Friday, November 15th.

Bionano Genomics Company Profile

Bionano Genomics, Inc provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA.